See up to 3 months of STEX. The 7-day demo opens the 1M and 3M ranges and puts STEX on your watchlist.
Start 7-day demoLatest STEX insider trades
About Streamex Corp. (STEX)
The SEC lists Streamex Corp. under CIK 0001530766, in electromedical and electrotherapeutic apparatus. It is grouped with Health Care companies on this site.
STEX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 151,571 | $95K |
| Tax withholding / forfeiture | 2 | 66,843 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
STEX insider transactions (Form 4)
4230 Form 4 filings on record, the earliest from Sep 16, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 65,538 | $0.54 footnote F2 | $35K | ||
| ||||||
| Christine Marie Plummer - Officer | Tax withholding / forfeiture | Common stock | 11,508 | $0.71 footnote F1 | $8K | |
| Christine Marie Plummer - Officer | Open-market sale | Common Stock | 13,344 | $0.54 footnote F3 | $7K | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 55,335 | $0.71 | $39K | ||
| Open-market sale | Common Stock | 72,689 | $0.72 footnote F3 | $52K | ||
| ||||||
| Shawn Matthews - Director | Grant or award | Common Stock | 100,000 | $0.00 footnote F1 | - | |
| ||||||
| Kevin Roy Gopaul - Director | Grant or award | Common Stock | 100,000 | $0.00 footnote F1 | - | |
| ||||||
| Morgan Lee Lekstrom - Officer | Open-market purchase | Common stock | 25,000 | $1.01 | $25K | |
| Morgan Lee Lekstrom - Officer | Open-market purchase | Common stock | 25,000 | $0.98 | $25K | |
| Open-market sale | Common Stock | 23,810 | $1.05 footnote F1 | $25K | ||
| ||||||
| Morgan Lee Lekstrom - Officer | Open-market purchase | Common stock | 34,000 | $1.47 | $50K | |
| Open-market purchase | Common stock | 17,745 | $1.13 footnote F1 | $20K | ||
| ||||||
| Morgan Lee Lekstrom - Officer | Open-market purchase | Common stock | 41,048 | $1.02 | $42K | |
| Morgan Lee Lekstrom - Officer | Open-market purchase | Common stock | 53,952 | $1.04 | $56K | |
| Morgan Lee Lekstrom - Officer | Open-market purchase | Common stock | 52,000 | $1.06 | $55K | |
| Grant or award | Common Stock | 2,250,000 | $0.00 footnote F1 | - | ||
| Open-market sale | Common Stock | 263,863 | $0.79 footnote F3 | $210K | ||
| ||||||
| Morgan Lee Lekstrom - Officer | Grant or award | Common stock | 100,000 | $0.00 footnote F1 | - | |
| Morgan Lee Lekstrom - Officer | Open-market sale | Common stock | 12,759 | $1.07 footnote F2 | $14K | |
| ||||||
| Karl Henry Michael McPhie - Officer | Grant or award | Common stock | 1,000,000 | $0.00 footnote F1 | - | |
| Karl Henry Michael McPhie - Officer | Open-market sale | Common stock | 30,611 | $1.07 footnote F2 | $33K | |
| ||||||
| Christine Marie Plummer - Officer | Open-market sale | Common stock | 10,922 | $1.10 footnote F1 | $12K | |
| Christine Marie Plummer - Officer | Open-market sale | Common stock | 2,581 | $1.08 footnote F1 | $3K | |
| ||||||
| Christine Marie Plummer - Officer | Grant or award | Common Stock | 500,000 | $0.00 footnote F1 | - | |
| ||||||
| Grant or award | Common Stock | 100,000 | $0.00 footnote F1 | - | ||
| ||||||
| Morgan Lee Lekstrom - Officer | Open-market purchase | Common Stock | 20,000 | $2.50 | $50K | |
| Frank Giustra - 10% Owner | Open-market purchase | Common Stock | 100,000 | $3.17 | $317K | |
| Morgan Lee Lekstrom - Director | Open-market purchase | Common Stock | 23,500 | $3.06 | $72K | |
| Morgan Lee Lekstrom - Director | Open-market purchase | Common Stock | 2,500 | $3.70 | $9K | |
| Frank Giustra - 10% Owner | Open-market purchase | Common Stock | 1,000,000 | $3.00 | $3.00M | |
| Morgan Lee Lekstrom - Director | Open-market purchase | Common Stock | 23,000 | $3.30 footnote F1 | $76K | |
| ||||||
| Open-market purchase | Common Stock | 51,511 | $3.03 footnote F1 | $156K | ||
| ||||||
| Morgan Lee Lekstrom - Director | Open-market purchase | Common Stock | 41,000 | $3.13 footnote F1 | $128K | |
| ||||||
| Kevin Roy Gopaul - Director | Grant or award | Common Stock | 100,000 | $0.00 | - | |
| Ferdinand Groenewald - Officer | Grant or award | Common Stock | 60,000 | $0.00 footnote F1 | - | |
| ||||||
| Morgan Lee Lekstrom - Director | Open-market purchase | Common Stock | 7,000 | $3.58 | $25K | |
| Donald Browne - Director | Grant or award | Common Stock | 125,000 | $0.00 footnote F1 | - | |
| ||||||
| Frank Giustra - 10% Owner | Open-market purchase | Common Stock | 4,975 | $4.64 | $23K | |
| Frank Giustra - 10% Owner | Open-market purchase | Common Stock | 11,399 | $4.66 | $53K | |
| Frank Giustra - 10% Owner | Open-market purchase | Common Stock | 6,424 | $4.69 | $30K | |
| Frank Giustra - 10% Owner | Open-market purchase | Common Stock | 27,202 | $4.72 | $128K | |
| Frank Giustra - 10% Owner | Open-market purchase | Common Stock | 128,205 | $3.90 | $500K | |
STEX insider trading FAQ
What is the latest insider trade for STEX?
Streamex Corp. (STEX) had 3 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for STEX runs to 30 Form 4 filings, the earliest from 2025-09-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying STEX stock?
No insider purchases of STEX were filed in the last 90 days. 21 purchases are on record for this company.
How many insiders are selling STEX stock?
3 insider sales of STEX were filed in the last 90 days, totaling $95K.
Where can I see STEX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects STEX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mitchell Young Williams view on EDGAR
- - Christine Marie Plummer view on EDGAR
- - Mitchell Young Williams view on EDGAR
- - Shawn Matthews view on EDGAR
- - Kevin Roy Gopaul view on EDGAR
- - Morgan Lee Lekstrom view on EDGAR
- - Mitchell Young Williams view on EDGAR
- - Morgan Lee Lekstrom view on EDGAR
- - Morgan Lee Lekstrom view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where STEX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow STEX with a 7-day demo
- STEX on your watchlist
- Every STEX Form 4 filing on record
- Up to 3 months of STEX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive